Abrogation of islet immunogenicity using an anti-MHC class I monoclonal antibody.
Munn
S R
SR
Department of Surgery, University of Auckland School of Medicine, Auckland Hospital, New Zealand.
Marjoribanks
C
C
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006825:Hybridomas / Q000276:immunology; D007515:Islets of Langerhans / Q000276:immunology*; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D015395:Histocompatibility Antigens Class I